44 7460 854 031

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Protein Therapeutics

Protein therapeutics and its empowering sister discipline, protein building, have risen since the mid 1980s. The main protein therapeutics were recombinant renditions of common proteins. Proteins intentionally changed to build their clinical potential before long followed with upgrades got from protein or glycoengineering, Fc combination or conjugation to polyethylene glycol. Counter acting agent based medications thusly emerged as the biggest and quickest developing class of protein therapeutics. The method of reasoning for growing better protein therapeutics with upgraded viability, more prominent wellbeing, decreased immunogenicity or improved conveyance originates from the assembly of clinical, logical, mechanical and business drivers that have recognized neglected needs and given procedures to address them.